2022-03-02
On the morning of March 2nd, Wang Wei, chairman of Canada Belan Biotechnology Group Co., Ltd., and his delegation visited Dahuanong Company for investigation and exchange, accompanied by Liu Xiaohui, deputy director of Zhaoqing Investment Promotion Bureau and other leaders. Chen Ruiai, chief operating officer of the Group and chairman of Dahuanong, received the research group.
The research group visited the exhibition hall of Dahuanong and the key laboratory of the Ministry of Agriculture. Chairman Chen Ruiai introduced the development process, scientific research innovation and transformation of achievements in detail. Wang Wei, chairman of Belan Group, highly recognized the achievements made in the past 20 years of animal vaccine and diagnostic testing by the company. The two sides exchanged views on the industrialization and application of medical testing chips, animal chips and cold chain chips, and discussed the breakthrough point for win-win cooperation in the future.
It is reported that Canada Belan Biotechnology Group is a high-tech enterprise in the development of medical testing chips and animal chips and supporting equipment, the production of biochips are mainly used in disease prevention diagnosis and treatment, new drug research and development, agriculture and animal husbandry, food safety and other fields. All-round, in-depth and multi-field exchanges and cooperation in biotechnology will help solve the problem of "bottleneck" in China's biochip imports.
Writing: Lin Man and Huang Jiebin
Photo: Huang Jiebin